VPS28

Across TCGA pan-cancer cohorts, VPS28 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of VPS28’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where VPS28 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types VPS28 is over-expressed in tumor, although a few such as HNSC and COAD show the opposite, repressed pattern.

LUAD, HNSC, and PDAC are the cancer types where VPS28 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in VPS28 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	II,III,IV	+0.243	<.001	9	view →
HNSC	Male	All	−0.231	<.001	8	view →
PDAC	Male	II,III,IV	+0.324	<.001	5	view →
COAD	All	All	−0.104	.019	2	view →
CCRCC	Male	All	−0.054	.009	2	view →
LSCC	All	All	−0.047	.014	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

VPS28–LUAD

Open the LUAD breakdown →